Click to Share
 
 
  1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution
Filter News
Show All Results
News By Country
News By Tag
Nmi Remove


October 2014
Tu Mo Su Sa Fr Th We
21 20 19 18 17 16 15

nmi Press Releases

  + XML/RSS  



By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. (NMI), a privately-held biopharmaceutical company dedicated to the development and commercialization of nanomedicines for the treatment of patients afflicted with multidrug resistant cancers, today announced the...

By Nemucore Medical Innovations, Inc.
Worcester Polytechnic Institute grants Provost Award to Joseph Cacaccio and Eileen Wrabel for their major qualifying project work at Nemucore Medical Innovations.

By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. (NMI) is a privately-held biopharmaceutical company dedicated to the development and commercialization of targeted nanomedicines for the treatment of patients afflicted with multidrug resistant cancers.

By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc., a privately-held biopharmaceutical company dedicated to the development and commercialization of nanomedicines for the treatment of patients afflicted with multidrug resistant cancers, today announced the publication...

All Press Releases

By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. (NMI), a privately-held biopharmaceutical company dedicated to the development and commercialization of nanomedicines for the treatment of patients afflicted with multidrug resistant cancers, today announced the...

By Nemucore Medical Innovations, Inc.
Worcester Polytechnic Institute grants Provost Award to Joseph Cacaccio and Eileen Wrabel for their major qualifying project work at Nemucore Medical Innovations.

By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. (NMI) is a privately-held biopharmaceutical company dedicated to the development and commercialization of targeted nanomedicines for the treatment of patients afflicted with multidrug resistant cancers.

By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc., a privately-held biopharmaceutical company dedicated to the development and commercialization of nanomedicines for the treatment of patients afflicted with multidrug resistant cancers, today announced the publication...

By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. (NMI), a privately-held biopharmaceutical company dedicated to the development and commercialization of nanomedicines for the treatment of patients afflicted with multidrug resistant cancers, today announced the...

By Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. (NMI) announces it has received a Phase I U43 Small Business Innovation research grant from the National Cancer Institute.

By Natural Marketing Institute
NMI has added Patti Marshman-Goldblatt as Senior Vice President and Diane Ray as Vice President-Strategic Consulting. Kurt Wagner, Dave Montgomery, La-Vie Borde-Perry, Gail Sayer and Deb Morang were hired as Project Directors.

By Nancy White
Fourth in a series of 10 releases based on NMI’s Top Ten Trends of 2007

By The Natural Marketing Institute
First in a series of seven trends based on NMI's extensive LOHAS consumer insight.



Page updated every 10 minutes


  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Service
  5. Copyright Notice
  6. About
  7. Advertise
Like PRLog?
9K2K1K
Click to Share